久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sinovac's COVID-19 vaccine 58.5% effective in preventing illness -Chile real world study

firstwordpharmaAugust 04, 2021

Tag: Sinovac , COVID-19 , Vaccine

Chilean health authorities said on Tuesday that Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic infection among millions of Chileans who received it between February and July, as reported This is Money

Sinovac's COVID-19 vaccine 58.5% effective in preventing illness -Chile real world study

Coronavac was 86% effective in preventing hospitalisation, 89.7% effective in preventing intensive care unit admission and 86% effective in preventing deaths within the population, said health official Rafael Araos.


Previous:Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Next:Rupture Disc Market in Industrial Machinery Industry | COVID-19 Impact & Recovery Analysis | Technavio

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service